// App-Quantinova.ai

6018 : PDL1-expressing circulating tumor cells (CTCs) in head and neck squamous cell carcinoma (HNSCC).

Researchers

Presenter

  • George Koutsodontis

Principal Investigators

  • Areti Strati

  • Margaritis Avgeris

  • Clarence Sasaki

  • Andreas Scorilas

  • Christos Perisanidis

  • Maria Vasilakopoulou

  • Alexios Strimpakos

  • Evi Lianidou

  • George Konstantinidis

  • Panagiota Economopoulou

  • Giannis Kotsantis

  • Kostas Tsigaridas

  • Elena Mihal Vagia

  • Nick Haralambakis

  • Amanda Psyrri

  • Eirini Maratou

  • Vassilios Ramfidis

Medical Centers

  • Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Athens, Athens, Greece

  • Yale University School of Medicine, New Haven, CT

  • University of Athens, Athens, Atiki, GreeceMedical University of Vienna, Vienna, AustriaAttikon Hospital, National Kapodistrian, University of Athens, Athens, Greece

  • Attikon Hospital, Athens, AZ, Greece

  • University of Athens Laboratory of Analytical Chemistry, Athens, Greece

  • Hopital de la Pitie-Salpetriere, Besancon, France

  • Attikon Hospital, Athens, AZ, Greece

  • Attikon Hospital, National Kapodistrian, University of Athens, Athens, Greece

  • Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Athens, Athens, Greece

Locations

  • United States

  • France

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma of the head and neck

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved